Becker's Healthcare September 3, 2025
A commonly available nasal spray may significantly reduce the risk of COVID-19 infections, according to clinical trial results.
Researchers from Saarland University Hospital in Germany led the study, the results of which were published Sept. 2 in JAMA Internal Medicine. They found that regular use of azelastine, an over-the-counter antihistamine nasal spray, lowered the incidence of SARS-CoV-2 infections in healthy adults. The phase 2, placebo-controlled trial involved 450 participants and ran from...
Today's Sponsors
Today's Sponsor